The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Gubareva N.N.

Kafedra nevrologii GBOU DPO Rossiĭskoĭ meditsinskoĭ akademii poslediplomnogo obrazovaniia, Moskva

Fedorova N.V.

NII skoroĭ pomoshchi im. N.V. Sklifosovskogo, Moskva

Tomskiĭ A.A.

FGBU "NII neĭrokhirurgii im. N.N. Burdenko" RAMN, Moskva

Gamaleia A.A.

Kafedra nevrologii Rossiĭskoĭ meditsinskoĭ akademii poslediplomnogo obrazovaniia, Tsentr kstrapiramidnykh zabolevaniĭ, Moskva

Poddubskaya A.A.

Burdenko Neurosurgical Institute, Moscow, Russia

Shabalov V.A.

FGBU "NII neĭrokhirurgii im. N.N. Burdenko" RAMN, Moskva

Omarova S.M.

Russian Medical Academy of Postgraduate Education, Centre for Extrapyramidal Disorders, Moscow, Russia

Effects of bilateral deep brain stimulation in the subthalamic nucleus using two methods of target structure verification

Authors:

Gubareva N.N., Fedorova N.V., Tomskiĭ A.A., Gamaleia A.A., Poddubskaya A.A., Shabalov V.A., Omarova S.M.

More about the authors

Read: 995 times


To cite this article:

Gubareva NN, Fedorova NV, Tomskiĭ AA, Gamaleia AA, Poddubskaya AA, Shabalov VA, Omarova SM. Effects of bilateral deep brain stimulation in the subthalamic nucleus using two methods of target structure verification. S.S. Korsakov Journal of Neurology and Psychiatry. 2017;117(11):24‑30. (In Russ.)
https://doi.org/10.17116/jnevro201711711124-30

Recommended articles:
Sarcopenia as a non-motor symptom of Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(9):15-22
Asso­ciation of inflammation and chro­nic fati­gue syndrome in patients with Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(9):79-87
Diagnosis and treatment approaches for sialorrhea in patients with Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(10):29-34
Neurochemical mechanisms of tremor in Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):64-72
Cognitive impairment in patients with Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):81-90
Bladder dysfunction in patients with stages I—III of Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):91-99
A portrait of a doctor with Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12):160-164

References:

  1. Deuschl G, Schüpbach M, Knudsen K, Pinsker M, Cornu P, Rau J, Agid Y, Schade-Brittinger C. Stimulation of the subthalamic nucleus at an earlier disease stage of Parkinson’s disease: Concept and standards of the EARLYSTIM-study. Parkinsonism & Related Disorders. 2013;19(1):56-61. https://doi.org/10.1016/j.parkreldis.2012.07.004
  2. Machado A, Deogaonkar M, Cooper S. Deep brain stimulation for movement disorders: Patient selection and technical options. Cleveland Clinic Journal of Medicine. 2012;79(suppl 2):19-24. https://doi.org/10.3949/ccjm.79.s2a.04
  3. deSouza R, Moro E, Lang A, Schapira A. Timing of deep brain stimulation in Parkinson disease: A need for reappraisal? Annals of Neurology. 2013;73(5):565-575. https://doi.org/10.1002/ana.23890
  4. Starr P, Ostrem J. Commentary on «Adaptive deep brain stimulation in advanced Parkinson disease». Annals of Neurology. 2013;74(3):447-448. https://doi.org/10.1002/ana.23966
  5. Pallidal versus Subthalamic Deep-Brain Stimulation for Parkinson’s Disease. 2011. New England Journal of Medicine. 2011;364(9):886-886. https://doi.org/10.1056/nejmx110012
  6. Paffi A, Camera F, Apollonio F, dâ Inzeo G, Liberti M. Numerical characterization of intraoperative and chronic electrodes in deep brain stimulation. Frontiers in Computational Neuroscience. 2015;9. https://doi.org/10.3389/fncom.2015.00002
  7. Shabalov VA, Tomskiĭ AA, Bril’ EV, Fedorova NV. Electrostimulation of a subthalamic nuclear area in Parkinson’s disease. Zh Vopr Neirokhir im. N.N. Burdenko. 2006;3:14-17. (In Russ.)
  8. Seifried C, Weise L, Hartmann R, Gasser T, Baudrexel S, Szelényi A, van de Loo S, Steinmetz H, Seifert V, Roeper J, Hilker R. Intraoperative microelectrode recording for the delineation of subthalamic nucleus topography in Parkinson’s disease. Brain Stimulation. 2012;5(3):378-387. https://doi.org/10.1016/j.brs.2011.06.002
  9. Gibb W, Lees A. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson’s disease. Journal of Neurology, Neurosurgery & Psychiatry. 1988;51(6):745-752. https://doi.org/10.1136/jnnp.51.6.745
  10. Hughes A, Ben-Shlomo Y, Daniel S, Lees A. What features improve the accuracy of clinical diagnosis in Parkinson’s disease: A clinicopathologic study. Neurology. 1992;42(6):1142-1142. https://doi.org/10.1212/wnl.42.6.1142
  11. Postuma R, Berg D, Stern M, Poewe W, Olanow C, Oertel W, Obeso J, Marek K, Litvan I, Lang A, Halliday G, Goetz C, Gasser T, Dubois B, Chan P, Bloem B, Adler C, Deuschl G. MDS clinical diagnostic criteria for Parkinson’s disease. Movement Disorders. 2015;30(12):1591-1601. https://doi.org/10.1002/mds.26424
  12. Langston J, Widner H, Goetz C, Brooks D, Fahn S, Freeman T, Watts R. Core assessment program for intracerebral transplantations (CAPIT). Movement Disorders. 1992;7(1):2-13. https://doi.org/10.1002/mds.870070103
  13. Hoehn M, Yahr M. Parkinsonism: onset, progression, and mortality. Neurology. 1967;17(5):427-427. https://doi.org/10.1212/wnl.17.5.427
  14. Lindvall O. Human Fetal Dopamine Neurons Grafted Into the Striatum in Two Patients With Severe Parkinson’s Disease. Archives of Neurology. 1989;46(6):615. https://doi.org/10.1001/archneur.1989.00520420033021
  15. Tinetti M. Performance-Oriented Assessment of Mobility Problems in Elderly Patients. Journal of the American Geriatrics Society. 1986;34(2):119-126. https://doi.org/10.1111/j.1532-5415.1986.tb05480.x
  16. Goetz C, Tilley B, Shaftman S, Stebbins G, Fahn S, Martinez-Martin P, Poewe W, Sampaio C, Stern M, Dodel R, Dubois B, Holloway R, Jankovic J, Kulisevsky J, Lang A, Lees A, Leurgans S, LeWitt P, Nyenhuis D, Olanow C, Rascol O, Schrag A, Teresi J, van Hilten J, LaPelle N. Movement Disorder Society-sponsored revision of the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results. Movement Disorders. 2008;23(15):2129-2170. https://doi.org/10.1002/mds.22340
  17. Peto V, Jenkinson C, Fitzpatrick R, Greenhall R. The development and validation of a short measure of functioning and well being for individuals with Parkinson’s disease. Quality of Life Research. 1995;4(3):241-248. https://doi.org/10.1007/bf02260863
  18. Schwab R, England A. Parkinson’s disease. Journal of Chronic Diseases. 1958;8(4):488-509. https://doi.org/10.1016/0021-9681(58)90006-7
  19. Fahn S, Elton RL, and members of the UPDRS Development Committee. Unified Parkinson’s disease rating scale. In: Fahn S, Marsden CD, Calne D, Goldstein M, eds. Recent developments in Parkinson’s disease. Florham Park, NJ: Macmillan Healthcare Information. 1987;153-163. https://doi.org/10.1016/B978-0-12-374105-9.00091-5
  20. Tomlinson C, Stowe R, Patel S, Rick C, Gray R, Clarke C. Systematic review of levodopa dose equivalency reporting in Parkinson’s disease. Movement Disorders. 2010;25(15):2649-2653. https://doi.org/10.1002/mds.23429
  21. Blomstedt P, Hariz M. Deep brain stimulation for movement disorders before DBS for movement disorders. Parkinsonism & Related Disorders. 2010;6(7):429-433. https://doi.org/10.1016/j.parkreldis.2010.04.005
  22. Bronte-Stewart H, Barberini C, Koop M, Hill B, Henderson J, Wingeier B. The СТЯ beta-band profile in Parkinson’s disease is stationary and shows prolonged attenuation after deep brain stimulation. Experimental Neurology. 2009;215(1):20-28. https://doi.org/10.1016/j.expneurol.2008.09.008
  23. Benabid A, Chabardes S, Mitrofanis J, Pollak P. Deep brain stimulation of the subthalamic nucleus for the treatment of Parkinson’s disease. The Lancet Neurology. 2009;8(1):67-81. https://doi.org/10.1016/s1474-4422(08)70291-6
  24. Lagrange E, Krack P, Moro E, Ardouin C, Van Blercom N, Chabardes S, Benabid A, Pollak P. Bilateral subthalamic nucleus stimulation improves health-related quality of life in PD. Neurology. 2002;59(12):1976-1978. https://doi.org/10.1212/01.wnl.0000037486.82390.1c
  25. Lanotte M. Deep brain stimulation of the subthalamic nucleus: anatomical, neurophysiological, and outcome correlations with the effects of stimulation. Journal of Neurology, Neurosurgery & Psychiatry. 2002;72(1):53-58. https://doi.org/10.1136/jnnp.72.1.53
  26. Vesper J, Klostermann F, Stockhammer F, Funk T, Brock M. Results of chronic subthalamic nucleus stimulation for Parkinson’s disease: a 1-year follow-up study. Surgical Neurology. 2002;57(5):306-311. https://doi.org/10.1016/s0090-3019(02)00691-2

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.